Antiviral drug allergy.
Milpied-Homsi B, Moran EM, Phillips EJ.
Immunol Allergy Clin North Am · research-article; review; journal article · DOI 10.1016/j.iac.2014.04.011 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för emtricitabine. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
19 hitsA randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.
Rockstroh JK, DeJesus E, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Plummer A, Abram M, Cheng AK, Fordyce MW, Szwarcberg J, GS-236-0103 Study Team.
J Acquir Immune Defic Syndr · clinical trial, phase iii; comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/qai.0b013e318286415cPrevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
Lambert-Niclot S, Charpentier C, Storto A, Fofana DB, Soulié C, Fourati S, Visseaux B, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG.
J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkt003Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.
Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, Fernandez C, Langness J, Kiser JJ, Bushman LR, Anderson PL.
AIDS Res Hum Retroviruses · research-article; evaluation study; journal article; research support, n.i.h., extramural · DOI 10.1089/aid.2012.0089Emtricitabine prodrugs with improved anti-HIV activity and cellular uptake.
Agarwal HK, Chhikara BS, Bhavaraju S, Mandal D, Doncel GF, Parang K.
Mol Pharm · research support, non-u.s. gov't; journal article · DOI 10.1021/mp300361aDuration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
Di Biagio A, Prinapori R, Giannarelli D, Maggiolo F, Di Giambenedetto S, Borghi V, Penco G, Cicconi P, Francisci D, Sterrantino G, Zoncada A, Monno L, Capetti A, Giacometti A, ARCA Collaborative Group.
J Antimicrob Chemother · research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1093/jac/dks339The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
Delahunty T, Bushman L, Robbins B, Fletcher CV.
J Chromatogr B Analyt Technol Biomed Life Sci · research-article; validation study; journal article; research support, n.i.h., extramural · DOI 10.1016/j.jchromb.2009.05.029Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers.
Zong J, Chittick GE, Wang LH, Hui J, Begley JA, Blum MR.
J Clin Pharmacol · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1177/0091270007300808A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F, Emtricitabine FTCB-301 Study Group.
Arch Intern Med · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1001/archinte.166.1.49Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.
Saag MS.
Clin Infect Dis · research support, non-u.s. gov't; review; journal article; research support, n.i.h., extramural · DOI 10.1086/498348Emtricitabine: new preparation. An antiretroviral very similar to lamivudine.
Författaruppgift saknas
Prescrire Int · comparative study; journal articleEmtricitabine: a novel nucleoside reverse transcriptase inhibitor.
Molina JM, Cox SL.
Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2005.41.4.900219Emtricitabine: a review of its use in the management of HIV infection.
Frampton JE, Perry CM.
Drugs · meta-analysis; review; journal article · DOI 10.2165/00003495-200565100-00008Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection.
Wang LH, Begley J, St Claire RL, Harris J, Wakeford C, Rousseau FS.
AIDS Res Hum Retroviruses · clinical trial, phase iii; clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1089/aid.2004.20.1173Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.
Saag MS, Cahn P, Raffi F, Wolff M, Pearce D, Molina JM, Powderly W, Shaw AL, Mondou E, Hinkle J, Borroto-Esoda K, Quinn JB, Barry DW, Rousseau F, FTC-301A Study Team.
JAMA · comparative study; clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1001/jama.292.2.180Emtricitabine (FTC) for the treatment of HIV infection.
Nelson M, Schiavone M.
Int J Clin Pract · review; journal article · DOI 10.1111/j.1368-5031.2004.00100.xPharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children.
Wang LH, Wiznia AA, Rathore MH, Chittick GE, Bakshi SS, Emmanuel PJ, Flynn PM.
Antimicrob Agents Chemother · clinical trial; research support, non-u.s. gov't; research-article; multicenter study; journal article · DOI 10.1128/aac.48.1.183-191.2004Emtricitabine: an antiretroviral agent for HIV infection.
Bang LM, Scott LJ.
Drugs · review; journal article · DOI 10.2165/00003495-200363220-00003Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor.
Richman DD.
Antivir Ther · review; journal article · DOI 10.1177/135965350100600201